BofA Securities Upgrades Ionis Pharmaceuticals (IONS) to Neutral, 'Higher revenue potential'
Tweet Send to a Friend
(Updated - October 23, 2023 6:12 AM EDT)
BofA Securities analyst Jason Gerberry upgraded Ionis Pharmaceuticals (NASDAQ: IONS) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
BofA Securities analyst Jason Gerberry upgraded Ionis Pharmaceuticals (NASDAQ: IONS) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
